Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition.
Saved in:
| Title: | Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition. |
|---|---|
| Authors: | Sundararajan V; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Ziyu F; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Elfar GA; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Genomics and Data Analytics Core (GeDaC), Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Kuay KT; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Tan A; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Lai C; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Wengner AM; Bayer AG, Pharmaceuticals, Berlin, Germany.; EPO Berlin-Buch GmbH, Berlin, Germany., Hung HT; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, Singapore., Qi M; Department of Gynecology Oncology, Singapore, Singapore., Chay WY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Cheok CF; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan DSP; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. david_sp_tan@nuhs.edu.sg.; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System Tower Block Level 7, Singapore, Singapore. david_sp_tan@nuhs.edu.sg. |
| Source: | Oncogene [Oncogene] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42277179 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sundararajan+V%22">Sundararajan V</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ziyu+F%22">Ziyu F</searchLink>; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Elfar+GA%22">Elfar GA</searchLink>; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+TZ%22">Tan TZ</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Genomics and Data Analytics Core (GeDaC), Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kuay+KT%22">Kuay KT</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+A%22">Tan A</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lai+C%22">Lai C</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wengner+AM%22">Wengner AM</searchLink>; Bayer AG, Pharmaceuticals, Berlin, Germany.; EPO Berlin-Buch GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Hung+HT%22">Hung HT</searchLink>; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Qi+M%22">Qi M</searchLink>; Department of Gynecology Oncology, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chay+WY%22">Chay WY</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Cheok+CF%22">Cheok CF</searchLink>; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+DSP%22">Tan DSP</searchLink>; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. david&#95;sp&#95;tan@nuhs.edu.sg.; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System Tower Block Level 7, Singapore, Singapore. david&#95;sp&#95;tan@nuhs.edu.sg. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2026 Jun 11. <i>Date of Electronic Publication: </i>2026 Jun 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42277179 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41388-026-03830-9 Languages: – Code: eng Text: English Titles: – TitleFull: Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sundararajan V – PersonEntity: Name: NameFull: Ziyu F – PersonEntity: Name: NameFull: Elfar GA – PersonEntity: Name: NameFull: Tan TZ – PersonEntity: Name: NameFull: Kuay KT – PersonEntity: Name: NameFull: Tan A – PersonEntity: Name: NameFull: Lai C – PersonEntity: Name: NameFull: Wengner AM – PersonEntity: Name: NameFull: Hung HT – PersonEntity: Name: NameFull: Qi M – PersonEntity: Name: NameFull: Chay WY – PersonEntity: Name: NameFull: Cheok CF – PersonEntity: Name: NameFull: Tan DSP IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2026 Jun 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5594 Titles: – TitleFull: Oncogene Type: main |
| ResultId | 1 |